Can a conversation aid empower lung cancer patients?

NCT ID NCT05407168

Recruiting now Knowledge-focused Sponsor: OHSU Knight Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a low-literacy conversation tool designed to help lung cancer patients and their doctors make treatment decisions together. Researchers will enroll 300 patients to see if the tool improves understanding, reduces confusion, and boosts confidence in choices. The focus is on patients with lower health literacy, aiming to make complex information easier to grasp.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: conversation tool (decision aid)
What this could lead to: If successful, this tool could help doctors and patients communicate better, leading to more informed and confident treatment choices for lung cancer.
What could go wrong: This is a behavioral study, not a drug trial. It may not change actual health outcomes, and results depend on how well the tool is used in practice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LUNG CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

lung carcinoma lung neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LUNG CARCINOMA

Contacts and locations

Locations

Adventist Health Portland
RECRUITING

Portland, Oregon, 97216, United States
Hillsboro Medical Center
RECRUITING

Hillsboro, Oregon, 97123, United States
OHSU Knight Cancer Institute
RECRUITING

Portland, Oregon, 97239, United States
Portland VA Medical Center
RECRUITING

Portland, Oregon, 97239, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.